Strosberg, J. R. (2012). A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial (RADIANT-3) of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: Updated Safety and Overall Survival Results. International Society of Gastrointestinal Oncology.
Chicago Style aipamenaStrosberg, Jonathan R. A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial (RADIANT-3) of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: Updated Safety and Overall Survival Results. International Society of Gastrointestinal Oncology, 2012.
MLA aipamenaStrosberg, Jonathan R. A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Trial (RADIANT-3) of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: Updated Safety and Overall Survival Results. International Society of Gastrointestinal Oncology, 2012.